The Generics Access Plan

Generic medicines have benefited millions of Americans and saved $1.5 trillion dollars in the past 10 years. And while much progress has been made, there are still too many off-patent medications that have few or no generic options.

With our Generics Access Plan we can help increase patient access to medicines by facilitating generics competition through new and revised standards, training and education, and collaborations with the FDA, industry representatives and others.

Explore what’s behind our trust in generic medicine with pharmacy professor Inma Hernández, Ph.D., PharmD.

Watch more episodes

generic medicine access
Call for Collaboration to support access to quality medicines
We are committed to support FDA’s List of Off-Patent, Off-Exclusivity Drug Products without an Approved Generic (OPOE) to expedite greater access for important generic drug therapies and help ensure quality and scientific rigor during drug development and manufacturing.

Read more

doctors with patient
Coalition expedites availability of generic drugs

The Call for Collaboration brings together engaged stakeholder organizations who are committed to increase access to quality generic medicines for legacy drugs without alternatives. Join this collaborative public health effort where public quality standards can help increase access to quality medicines for patients who need them.

Contact us at to obtain additional information.

Standards linked to more generics and lower drug costs

A recently published study by Johns Hopkins University found that drugs with a USP standard have approximately 50% more generic manufacturers in the U.S. than those without a standard. This increased competition was associated with reducing prescription drug costs.

Read the study

Ron Piervincenzi
Our legacy of championing access to medicines

Ron Piervincenzi, Ph.D., shares his thoughts on USP receiving the Association of Accessible Medicines (AAM) Champion of Access award.

Read the blog post

pharmacist portioning out pills
Similarity and difference in the world of drugs

Jeremy Greene, M.D., Ph.D., Professor of Medicine and the History of Medicine, The Johns Hopkins School of Medicine, and author of Generic: The Unbranding of Modern Medicine, answers questions about the history of generic medicines.

Read the Q&A

timeline image
Generic medicines: a history

Generics have advanced rapidly over the last 55 years. View the milestones in their advancement since 1962.

See the timeline